ESR1 and breast cancer: Likewise, Qi et al. [27] suggested a cut-off of RDI ≥ 85% or ≥80% to improve disease-free and overall survival for ER+ patients and ER- patients, respectively, based on a retrospective analysis of 293 patients with breast cancer from Western China.